FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to obstetrics, and can be used for preventing placental dysfunction in gestational pyelonephritis. That is ensured by the standard position therapy, infusion, antibacterial, spasmolytic, phytotherapy. Plasmapheresis is performed on the first and third day of treatment. In addition, from the first day of treatment, progesterone preparations Utrozhestan© 100 mg or Duphaston® 10 mg every 12 hours, per os, daily, before pregnancy 37 weeks + 1 day are prescribed.
EFFECT: method provides effective prevention of placental dysfunction and associated obstetric complications in acute gestational pyelonephritis, safe for a pregnant woman and fetus by stabilizing a hormonal background in pregnant women, creating favorable conditions for further prolongation of pregnancy.
1 cl, 5 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTION OF COMPLICATIONS IN PERITONEAL COMMISSURES GESTATION ACUTE INTESTINAL OBSTRUCTION IN PREGNANT WOMEN | 2015 |
|
RU2578541C1 |
METHOD FOR PREVENTION OF PREMATURE DELIVERY IN ACUTE PANCREATITIS IN PREGNANT WOMEN | 2014 |
|
RU2535108C1 |
METHOD FOR PREDICTION OF EARLY AND LATE PREECLAMPSIA | 2018 |
|
RU2693412C1 |
METHOD FOR PREVENTING PATHOLOGICAL PREGNANCY SYNDROME | 2015 |
|
RU2575789C1 |
METHOD OF PREVENTING MISCARRIAGE AFTER APPENDECTOMY | 2012 |
|
RU2475277C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF CRITICAL CONDITIONS OF WOMEN DURING CHILDBEARING AND DURING THE PUERPERIUM | 2017 |
|
RU2647459C1 |
METHOD FOR PREDICTION OF OBSTETRIC PATHOLOGY | 2007 |
|
RU2339954C1 |
METHOD FOR PREDICTION OF COMPLICATED PREGNANCY IN WOMEN WITH GENITAL ENDOMETRIOSIS | 2017 |
|
RU2640022C1 |
METHOD FOR PREDICTING PRIMARY PLACENTA INSUFFICIENCY SEVERITY DEGREE | 2005 |
|
RU2292552C2 |
METHOD FOR PREDICTING CEREBRAL DISORDERS IN NEONATALS IN MOTHERS FROM HIGH-RISK GROUP | 2005 |
|
RU2290644C1 |
Authors
Dates
2019-07-15—Published
2018-03-21—Filed